Conversion of amylase-secreting rat pancreatic AR42J cells to neuronlike cells by activin A

The Journal of Clinical Investigation
H OhnishiHiroshi Ishikawa

Abstract

When AR42J cells, an amylase-secreting pancreatic exocrine cell line, were treated with activin A, cells extended neuritelike processes, and, concomitantly, amylase-containing vesicles disappeared. Immunofluorescence and immunoelectron microscopy revealed that these processes had neurite-specific cytoskeletal architectures: neurofilaments and microtubule bundles with cross-bridges of microtubule-associated protein 2. In addition to such morphological changes, activin-treated cells exhibited a marked increase in cytoplasmic free calcium concentration in response to depolarizing concentration of potassium. Moreover, activin-treated AR42J cells expressed mRNA for alpha 1 subunit of the neuroendocrine/beta cell-type voltage-dependent calcium channel. In naive AR42J cells, a sulfonylurea compound, tolbutamide, did not affect free calcium concentration, while it induced a marked elevation of free calcium in activin-treated cells. Single channel recording of the membrane patch revealed the existence of ATP-sensitive potassium channel in activin-treated cells. These results indicate that activin A converts amylase-secreting AR42J cells to neuronlike cells. Given that pancreatic endocrine cells possess neuronlike properties and express ...Continue Reading

References

Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S SeinoG I Bell
May 1, 1991·Trends in Neurosciences·M GoedertC C Garner
Mar 1, 1991·Journal of Neuroscience Methods·J RaeM Watsky
Mar 5, 1990·Molecular and Cellular Endocrinology·T KatayamaM Takahashi
Nov 30, 1990·Biochemical and Biophysical Research Communications·M HashimotoM Muramatsu
Apr 26, 1990·Nature·D SchubertW H Fischer
Jun 1, 1989·Trends in Neurosciences·M M Black, P W Baas
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·B WiedenmannV E Gould
May 31, 1988·Biochemical and Biophysical Research Communications·H SuginoK Titani
Feb 13, 1987·Biochemical and Biophysical Research Communications·Y EtoH Shibai
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Feb 1, 1995·Endocrine Journal·M FurukawaI Kojima
Apr 22, 1994·Cell·A Hemmati-Brivanlou, D A Melton
Sep 1, 1993·The Journal of Clinical Investigation·H YasudaI Kojima

❮ Previous
Next ❯

Citations

Oct 22, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·K UmezawaT-S Kam
Jul 23, 1999·Annals of the New York Academy of Sciences·R JesnowskiM Löhr
Jan 29, 2005·International Journal of Experimental Pathology·Joanna LaursonHumphrey J F Hodgson
Apr 9, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·You-Qing ZhangNora Sarvetnick
Sep 11, 2010·International Journal of Cancer. Journal International Du Cancer·Marlène DufresneVéronique Gigoux
Sep 24, 2004·IEEE Transactions on Nanobioscience·Ann-Sofie AnderssonDuncan S Sutherland
Dec 13, 2005·The International Journal of Biochemistry & Cell Biology·Itaru Kojima, Kazuo Umezawa
Feb 27, 2004·Biochemical and Biophysical Research Communications·Kouji HamaKentaro Sugano
May 3, 2005·Journal of Cellular Biochemistry·Yukako YoshikumiItaru Kojima
Mar 21, 2003·The Journal of Biological Chemistry·Hirosato MashimaItaru Kojima
Sep 22, 2006·Molecular Endocrinology·Aline Mamin, Jacques Philippe
Jun 28, 2003·The Journal of Biological Chemistry·Daniel M KempJoel F Habener
Dec 14, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hiroshi Takatsuna, Kazuo Umezawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.